You have 9 free searches left this month | for more free features.

Condition

Neuroendocrine Tumors (2)

Neuroblastoma (1)

Refractory Neuroblastoma (1)

Relapsed Neuroblastoma (1)

Overall Status

Recruiting (2)

Completed (1)

Sign in for free

Phase

early phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Clarity Pharmaceuticals Ltd (3)

Collaborator

Intervention

64cu-sartate (3)

67cu-sartate (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

64cu-sartate

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neuroendocrine Tumors Trial in Australia (64Cu-SARTATE)

Recruiting

Neuroendocrine Tumors

64Cu-SARTATE

Kingswood, New South Wales, Australia
+3 more

May 17, 2022

Neuroblastoma, Relapsed Neuroblastoma, Refractory Neuroblastoma Trial in United States (67Cu-SARTATE, 64Cu-SARTATE)

Recruiting

Neuroblastoma
+2 more

67Cu-SARTATE
64Cu-SARTATE

Phoenix, Arizona
+8 more

Jun 29, 2022

Neuroendocrine Tumors Trial (64Cu-SARTATE)

Completed

Neuroendocrine Tumors

64Cu-SARTATE

(no location specified)

Jun 18, 2020